In a report released yesterday, Leland Gershell from Oppenheimer assigned a Buy rating to Outlook Therapeutics (OTLK – Research Report),
Category: Healthcare
Oppenheimer Gives a Buy Rating to Sierra Oncology (SRRA)
In a report released yesterday, Jay Olson from Oppenheimer assigned a Buy rating to Sierra Oncology (SRRA – Research Report),
Ayala Pharmaceuticals (AYLA) Gets a Buy Rating from Oppenheimer
Oppenheimer analyst Jay Olson maintained a Buy rating on Ayala Pharmaceuticals (AYLA – Research Report) yesterday and set a price
Raymond James Keeps a Hold Rating on Aerie Pharma (AERI)
In a report released today, Elliot Wilbur from Raymond James maintained a Hold rating on Aerie Pharma (AERI – Research
Antares Pharma (ATRS) Receives a Buy from Raymond James
Raymond James analyst Elliot Wilbur maintained a Buy rating on Antares Pharma (ATRS – Research Report) today. The company’s shares
Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA), Teva Pharmaceutical Industries (NYSE: TEVA) and Leap Therapeutics (NASDAQ: LPTX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Moderna (MRNA
Oppenheimer Issues a Buy Rating on MannKind (MNKD)
In a report released today, Steven Lichtman from Oppenheimer assigned a Buy rating to MannKind (MNKD – Research Report), with